Artificial Intelligence (AI) is poised to transform drug discovery, ushering in an era of unprecedented innovation in the pharmaceutical industry. The promise of developing numerous high-quality drug candidates quickly and cost-effectively is becoming a reality. However, this revolution also brings
In a bold move that underscores the dynamism of the pharmaceutical industry, Ono Pharmaceutical Co., Ltd. has executed a major acquisition of Deciphera Pharmaceuticals Inc. The deal, valued at a hefty $2.4 billion, positions Ono strategically as a more influential player on the global stage,
The pharmaceutical landscape is witnessing a dynamic shift as companies like Contract Pharmaceuticals Limited (CPL) embrace new ownership structures aimed at invigorating their strategic direction. When a company of CPL's stature undergoes significant change, it signals to the industry potential
The recent unveiling of the Sefia manufacturing platform by Cytiva, in partnership with Gilead Sciences’ Kite Pharma, marks a transformative step in the field of CAR-T cell therapy. With demand for these life-saving treatments increasing, the traditional production methods, fraught with manual
The pharmaceutical industry confronts a pivotal moment as the imperative to integrate sustainability throughout supply chains gains momentum. Amid shifting paradigms, companies are increasingly aware that business success is no longer measured solely in financial terms. Today's corporate climate
The quest for effective treatments in the fight against metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as non-alcoholic steatohepatitis (NASH), has reached an exciting new threshold. Boehringer Ingelheim has shared groundbreaking results from their Phase II clinical
In a significant move aimed at boosting the development of cell and gene therapies, Bionova Scientific, a part of the Asahi Kasei Group, has announced an ambitious $100 million investment. This investment will see the creation of a new state-of-the-art plasmid DNA (pDNA) production facility in The
In the rapidly-changing environment of the pharmaceutical industry, the innovative stride of Pharma 4.0 heralds a new era of drug production. This pivotal shift to smart manufacturing aligns with the principles of Industry 4.0, embedding digitalization and cutting-edge technology to meet the
Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic
In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a cautious stance
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy